Insider trading

Period: 120 months Stock: MRK Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

98 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

98 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

98 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

98 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
98 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
98 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

98 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Feb 2023
Romanelli Joseph President, Human Health Int?l
Sold, plan not stated
$541.10K 5,000 at 108.22
19.8%
13 Feb 2023
MIZELL STEVEN EVP, Chief HR Officer
Sold, plan not stated
$198.02K 1,815 at 109.10
5.2%
9 Feb 2023
MIZELL STEVEN EVP, Chief HR Officer
Sold, plan not stated
$535.01K 5,000 at 107.00
12.5%
6 Feb 2023
MIZELL STEVEN EVP, Chief HR Officer
Sold, plan not stated
$462.47K 4,436 at 104.25
10.0%
3 Feb 2023
Zachary Jennifer EVP, General Counsel
Sold, plan not stated
$7.78M 75,436 at 103.17
58.3%
Sold half or more
9 Jan 2023
Chattopadhyay Sanat Exe V-P & Pres. MMD
Sold, plan not stated 5×
$9.43M 83,994 at 112.29
74.0%
Sold half or more
10 Nov 2022
MIZELL STEVEN EVP, Chief HR Officer
Sold, plan not stated
$1.52M 15,000 at 101.42
31.8%
9 Nov 2022
Davis Robert M CEO & President
Sold, plan not stated 3×
$17.17M 167,613 at 102.44
40.4%
9 Nov 2022
Oosthuizen Johannes Jacobus President, U.S. Market
Sold, plan not stated
$185.26K 1,795 at 103.21
9.7%
8 Nov 2022
MIZELL STEVEN EVP, Chief HR Officer
Sold, plan not stated
$2.02M 20,000 at 101.00
38.4%
7 Nov 2022
FRAZIER KENNETH C Executive Chair
Sold, plan not stated 3×
$23.47M 235,769 at 99.55
25.2%
7 Nov 2022
Oosthuizen Johannes Jacobus President, U.S. Market
Sold, plan not stated
$4.53M 45,561 at 99.47
71.1%
Sold half or more
4 Nov 2022
FRAZIER KENNETH C Executive Chair
Sold, plan not stated 2×
$23.17M 235,000 at 98.61
25.1%
3 Nov 2022
FRAZIER KENNETH C Executive Chair
Sold, plan not stated 2×
$23.20M 235,000 at 98.71
25.1%
2 Nov 2022
FRAZIER KENNETH C Executive Chair
Sold, plan not stated 2×
$29.97M 300,000 at 99.91
30.0%
1 Nov 2022
FRAZIER KENNETH C Executive Chair
Sold, plan not stated 3×
$29.94M 300,000 at 99.81
29.8%
31 Oct 2022
FRAZIER KENNETH C Executive Chair
Sold, plan not stated 2×
$30.22M 300,000 at 100.75
29.8%
28 Oct 2022
FRAZIER KENNETH C Executive Chair
Sold, plan not stated 3×
$56.87M 567,084 at 100.28
44.5%
28 Oct 2022
DeLuca Richard R. EVP&Pres, Merck Animal Heallth
Sold, plan not stated
$16.50M 164,557 at 100.26
54.6%
Sold half or more
28 Oct 2022
Zachary Jennifer EVP, General Counsel
Sold, plan not stated 2×
$16.42M 165,255 at 99.38
81.3%
Sold half or more
28 Oct 2022
Chattopadhyay Sanat Exe V-P & Pres. MMD
Sold, plan not stated
$10.04M 100,292 at 100.10
68.7%
Sold half or more
28 Oct 2022
Karachun Rita A Sr. VP Fince-Global Controller
Sold, plan not stated
$3.21M 31,997 at 100.34
43.8%
28 Oct 2022
MIZELL STEVEN EVP, Chief HR Officer
Sold, plan not stated 2×
$2.49M 25,000 at 99.63
43.7%
28 Oct 2022
Oosthuizen Johannes Jacobus President, U.S. Market
Sold, plan not stated
$364.06K 3,633 at 100.21
25.0%
9 Nov 2021
FRAZIER KENNETH C Executive Chair
Sold, plan not stated 2×
$54.61M 663,881 at 82.26
53.1%
Sold half or more
4 Nov 2021
DeLuca Richard R. EVP&Pres, Merck Animal Heallth
Sold, plan not stated
$2.69M 29,782 at 90.40
20.3%
4 Nov 2021
Sold, plan not stated
$1.67M 18,335 at 91.00
43.2%
3 Nov 2021
Karachun Rita A Sr. VP Fince-Global Controller
Sold, plan not stated
$2.21M 25,000 at 88.45
41.1%
1 Nov 2021
Gerberding Julie L. EVP, Chief Patient Officer
Sold, plan not stated
$8.46M 96,270 at 87.91
71.1%
Sold half or more
1 Nov 2021
Clyburn Frank EVP & Pres ? Human Health
Sold, plan not stated
$3.49M 39,762 at 87.87
29.1%
29 Oct 2021
DeLuca Richard R. EVP&Pres, Merck Animal Heallth
Sold, plan not stated
$11.86M 135,405 at 87.56
53.7%
Sold half or more
29 Oct 2021
Chattopadhyay Sanat Exe V-P & Pres. MMD
Sold, plan not stated
$2.15M 24,619 at 87.32
20.9%
10 May 2021
Clyburn Frank EVP & Pres ? Human Health
Sold, plan not stated
$1.51M 19,324 at 78.32
17.0%
9 Nov 2020
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated 2×
$22.80M 280,000 at 81.42
40.5%
5 Oct 2020
Davis Robert M EVP, Global Svcs & CFO
Sold, plan not stated
$20.36M 251,273 at 81.03
59.5%
Sold half or more
13 Aug 2020
Chattopadhyay Sanat Exe V-P & Pres. MMD
Sold, plan not stated
$861.68K 10,380 at 83.01
13.3%
5 Aug 2020
Clyburn Frank EVP, Chief Commercial Officer
Sold, plan not stated
$1.54M 18,876 at 81.55
18.9%
17 Jul 2020
Gerberding Julie L. EVP Strat Comm, GI Pub Policy
Sold, plan not stated 2×
$2.90M 36,285 at 80.00
57.7%
Sold half or more
7 May 2020
WEEKS WENDELL P Director
Sold, plan not stated
$380.10K 5,000 at 76.02
98.0%
Sold half or more
7 May 2020
BRUN LESLIE A Director
Sold, plan not stated
$377.30K 5,000 at 75.46
72.0%
Sold half or more
13 Jan 2020
Gerberding Julie L. EVP Strat Comm, GI Pub Policy
Sold, plan not stated
$9.12M 102,073 at 89.34
73.4%
Sold half or more
9 Aug 2019
DeLuca Richard R. EVP&Pres, Merck Animal Heallth
Sold, plan not stated
$546.85K 6,427 at 85.09
8.2%
8 Aug 2019
DeLuca Richard R. EVP&Pres, Merck Animal Heallth
Sold, plan not stated
$2.69M 31,699 at 85.01
30.7%
25 Jun 2019
Davis Robert M EVP, Global Svcs & CFO
Sold, plan not stated 2×
$18.51M 216,718 at 85.43
61.2%
Sold half or more
7 May 2019
Clyburn Frank EVP, Chief Commercial Officer
Sold, plan not stated
$1.94M 25,000 at 77.73
27.0%
3 May 2019
DeLuca Richard R. EVP&Pres, Merck Animal Heallth
Sold, plan not stated
$2.80M 35,000 at 80.00
33.0%
25 Mar 2019
Davis Robert M EVP, Global Svcs & CFO
Sold, plan not stated
$15.86M 192,572 at 82.38
58.3%
Sold half or more
20 Mar 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$15.81M 192,736 at 82.05
19.5%
13 Mar 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$1.54M 18,725 at 82.00
2.3%
5 Mar 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$570.81K 6,961 at 82.00
0.9%
Showing 1–50 of 98. Page 1 of 2 Older →